We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACI
176
AMP Capital Investors
Australia
$8.37M +$8.4M +215,718 New
CM
177
Capital Management
Virginia
$8.12M +$8.07M +207,236 New
BG
178
Bahl & Gaynor
Ohio
$7.75M +$7.69M +197,580 New
LCS
179
Levin Capital Strategies
New York
$7.7M +$7.65M +196,540 New
Mitsubishi UFJ Trust & Banking
180
Mitsubishi UFJ Trust & Banking
Japan
$7.7M +$7.65M +196,500 New
QAM
181
QCI Asset Management
New York
$7.68M +$7.64M +196,056 New
TH
182
TCTC Holdings
Texas
$7.34M +$7.29M +187,137 New
RS
183
Robeco Schweiz
Switzerland
$7.19M +$7.22M +185,500 New
SAM
184
Strategy Asset Managers
California
$7.05M +$7.01M +179,939 New
Comerica Bank
185
Comerica Bank
Texas
$7.02M +$6.97M +179,081 New
Natixis Advisors
186
Natixis Advisors
Massachusetts
$6.92M +$6.87M +176,405 New
Luther King Capital Management (LKCM)
187
Luther King Capital Management (LKCM)
Texas
$6.9M +$6.85M +176,002 New
DJSG
188
D.J. St. Germain
Massachusetts
$6.77M +$6.73M +172,722 New
ACM
189
Academy Capital Management
Texas
$6.7M +$6.65M +170,839 New
PAM
190
Panagora Asset Management
Massachusetts
$6.69M +$6.65M +170,672 New
MC
191
Muhlenkamp & Co
Pennsylvania
$6.65M +$6.61M +169,660 New
CBOA
192
Commonwealth Bank of Australia
Australia
$6.65M +$6.6M +169,595 New
TRSOTSOK
193
Teachers Retirement System of the State of Kentucky
Kentucky
$6.52M +$6.48M +166,300 New
MIH
194
Madison Investment Holdings
Wisconsin
$6.47M +$6.43M +165,000 New
CCM
195
Cohen Capital Management
California
$6.37M +$6.33M +162,550 New
HIMC
196
Heritage Investors Management Corp
Maryland
$6.28M +$6.24M +160,163 New
HNB
197
Huntington National Bank
Ohio
$6.14M +$6.1M +156,631 New
SC
198
Sculptor Capital
New York
$6.08M +$6.03M +154,968 New
PA
199
Pinnacle Associates
New York
$5.98M +$5.94M +152,532 New
TM
200
TigerShark Management
New York
$5.98M +$5.94M +152,488 New
6 7
8
9 10

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.